These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo. Hintz-Obertreis P, Weinmann E, Seiler FR. Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901 [Abstract] [Full Text] [Related]
23. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Carlo-Stella C, Cazzola M, Bergamaschi G, Bernasconi P, Dezza L, Invernizzi R, Pedrazzoli P. Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496 [Abstract] [Full Text] [Related]
25. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S. Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [Abstract] [Full Text] [Related]
26. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Bacigalupo A, Piaggio G, Podestá M, Raffo MR, Tedone E, Sogno G, Benvenuto F, Figari O, Grassia L, Bagnara GP. Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324 [Abstract] [Full Text] [Related]
27. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia. Wright DG, LaRussa VF, Salvado AJ, Knight RD. J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515 [Abstract] [Full Text] [Related]
28. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Gibson FM, Scopes J, Daly S, Ball SE, Gordon-Smith EC. Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428 [Abstract] [Full Text] [Related]
29. Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF). Caruana G, Ashman LK, Fujita J, Gonda TJ. Exp Hematol; 1993 Jun; 21(6):761-8. PubMed ID: 7684700 [Abstract] [Full Text] [Related]
30. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM. Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640 [Abstract] [Full Text] [Related]
32. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation. Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A. Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338 [Abstract] [Full Text] [Related]
33. Influence of murine mast cell growth factor (c-kit ligand) on colony formation by mouse marrow hematopoietic progenitor cells. Broxmeyer HE, Hangoc G, Cooper S, Anderson D, Cosman D, Lyman SD, Williams DE. Exp Hematol; 1991 Feb; 19(2):143-6. PubMed ID: 1703968 [Abstract] [Full Text] [Related]
34. Co-stimulatory effects of steel factor, the c-kit ligand, on purified human hematopoietic progenitors in low cell density culture. Li ML, Cardoso A, Sansilvestri P, Hatzfeld A, Kisselev S, Batard P, Levesque JP, Hatzfeld J. Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):81-6. PubMed ID: 7685520 [Abstract] [Full Text] [Related]
35. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone. Musto P, Sanpaolo G, D'Arena G, Scalzulli PR, Matera R, Falcone A, Bodenizza C, Perla G, Carotenuto M. Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570 [Abstract] [Full Text] [Related]
36. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Broxmeyer HE, Hangoc G, Cooper S, Ribeiro RC, Graves V, Yoder M, Wagner J, Vadhan-Raj S, Benninger L, Rubinstein P. Proc Natl Acad Sci U S A; 1992 May 01; 89(9):4109-13. PubMed ID: 1373894 [Abstract] [Full Text] [Related]
37. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando ML, Piacibello W. Exp Hematol; 1989 Mar 01; 17(3):296-9. PubMed ID: 2783914 [Abstract] [Full Text] [Related]
38. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Haematologica; 1997 Mar 01; 82(3):291-6. PubMed ID: 9234574 [Abstract] [Full Text] [Related]
39. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells. Goff JP, Shields DS, Boggs SS, Greenberger JS. Radiat Res; 1997 Jan 01; 147(1):61-9. PubMed ID: 8989371 [Abstract] [Full Text] [Related]
40. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents. Ulich TR, Yi ES, Yin S, del Castillo J, McNiece I, Yung YP, Zsebo KM. Int Rev Exp Pathol; 1993 Jan 01; 34 Pt A():215-33. PubMed ID: 7681048 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]